Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Kallikrein Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
HUMAN C1-ESTERASE INHIBITOR 14,344 1,403 9.8% 3,966 1,312 42.7 yrs 79.1%
LANADELUMAB 2,058 109 5.3% 1,007 63 47.3 yrs 75.7%
ECALLANTIDE 1,206 23 1.9% 499 14 42.9 yrs 84.1%
BEROTRALSTAT 548 24 4.4% 128 9 45.9 yrs 74.7%

Head-to-Head Comparisons

HUMAN C1-ESTERASE INHIBITOR vs LANADELUMAB HUMAN C1-ESTERASE INHIBITOR vs ECALLANTIDE HUMAN C1-ESTERASE INHIBITOR vs BEROTRALSTAT LANADELUMAB vs ECALLANTIDE LANADELUMAB vs BEROTRALSTAT ECALLANTIDE vs BEROTRALSTAT
← Back to Kallikrein Inhibitors [MoA] Class side effects →